Heron Therapeutics HRTX
NASDAQ HRTX
$0.36 +0.04 (+13.52%)
At close: Oct 1, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Heron Therapeutics' Liabilities and Shareholders Equity came in at $252.26 million for Q2 2026, up 8.7% from $232.09 million a year earlier and up 2.5% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Heron Therapeutics' Liabilities and Shareholders Equity was $255.88 million, up 9.7% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $233.15 million in FY2024 (+4.8%), $222.51 million in FY2023 (-11.3%), $250.95 million in FY2022 (-17.9%) and $305.71 million in FY2021 (-13.5%).
  • The five-year range for quarterly Liabilities and Shareholders Equity is $201.22 million (Q2 2023) to $352.39 million (Q3 2021).
  • Year-over-year, Liabilities and Shareholders Equity has increased for seven consecutive quarters, with growth averaging 6.4% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2025 (growth of 12.8%), and the weakest in Q2 2022 (a decline of 39.6%).
  • Business Quant data shows HRTX's Liabilities and Shareholders Equity at $246.22 million (Q1 2026), $255.88 million (Q4 2025) and $248.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Heron Therapeutics 58.85 Mn -130.71 Mn 26.09 Mn 252.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 252.26 Mn
Mar 31, 2026 246.22 Mn
Dec 31, 2025 255.88 Mn
Sep 30, 2025 248.95 Mn
Jun 30, 2025 232.09 Mn
Mar 31, 2025 235.75 Mn
Dec 31, 2024 233.15 Mn
Sep 30, 2024 220.78 Mn
Jun 30, 2024 218.14 Mn
Mar 31, 2024 217.89 Mn
Dec 31, 2023 222.51 Mn
Sep 30, 2023 229.20 Mn
Jun 30, 2023 201.22 Mn
Mar 31, 2023 220.88 Mn
Dec 31, 2022 250.95 Mn
Sep 30, 2022 271.95 Mn
Jun 30, 2022 243.97 Mn
Mar 31, 2022 273.72 Mn
Dec 31, 2021 305.71 Mn
Sep 30, 2021 352.39 Mn
API Access

Heron Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=HRTX&period=max&api_key=YOUR_API_KEY